Novo Nordisk Shares Plummet as Wegovy Knockoffs Weigh on Sales
The pharmaceutical giant’s shares fell as much as 30% after it cut its guidance and said U.S. sales of Ozempic grew more slowly.
Source: MSN The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments